It should be noted that the cancer antigen 15-3 (CA15-3) and the carcinoembryonic antigen (CEA) have been approved by Food and Drug Administration (FDA) as tumor markers for breast cancer. This evidence concerns the gene CEACAM5 and breast cancer.